The economic burden of overweight and obesity in Saudi Arabia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 27 09 2021
accepted: 21 02 2022
entrez: 8 3 2022
pubmed: 9 3 2022
medline: 28 4 2022
Statut: epublish

Résumé

The prevalence of overweight and obesity in Saudi Arabia has been rising. Although the health burden of excess weight is well established, little is known about the economic burden. To assess the economic burden-both direct medical costs and the value of absenteeism and presenteeism-resulting from overweight and obesity in Saudi Arabia. The cost of overweight and obesity in Saudi Arabia was estimated from a societal perspective using an epidemiologic approach. Data were obtained from previously published studies and secondary databases. Overweight/obesity-attributable costs were calculated for six major noncommunicable diseases; sensitivity analyses were conducted for key model parameters. The impact of overweight and obesity for these diseases is found to directly cost a total of $3.8 billion, equal to 4.3 percent of total health expenditures in Saudi Arabia in 2019. Estimated overweight and obesity-attributable absenteeism and presenteeism costs a total of $15.5 billion, equal to 0.9 percent of GDP in 2019. Even when limited to six diseases and a subset of total indirect costs, results indicate that overweight and obesity are a significant economic burden in Saudi Arabia. Future studies should identify strategies to reduce the health and economic burden resulting from excess weight in Saudi Arabia.

Identifiants

pubmed: 35259190
doi: 10.1371/journal.pone.0264993
pii: PONE-D-21-31162
pmc: PMC8903282
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0264993

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Appl Health Econ Health Policy. 2013 Dec;11(6):671-5
pubmed: 24174262
Eur J Health Econ. 2016 Jan;17(1):61-9
pubmed: 25432787
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Eur J Health Econ. 2015 Dec;16(9):957-67
pubmed: 25381038
J Med Econ. 2021 Jan-Dec;24(1):828-834
pubmed: 34138664
Eur J Health Econ. 2016 Dec;17(9):1141-1158
pubmed: 26701837
Obes Rev. 2010 Jan;11(1):31-40
pubmed: 19413707
PLoS One. 2015 Apr 01;10(4):e0121160
pubmed: 25830909
Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31
pubmed: 19635784
Int J Pediatr Obes. 2008;3 Suppl 1:51-7
pubmed: 18278633
Econ Hum Biol. 2020 Aug;38:100868
pubmed: 32302767
Health Econ. 2016 Oct;25(10):1291-311
pubmed: 26223895
Lancet. 2016 Sep 24;388(10051):1311-24
pubmed: 27475266
Ann Plast Surg. 2008 May;60(5):502-4
pubmed: 18434822

Auteurs

Jesse D Malkin (JD)

World Bank Group Consultant, Colorado Springs, Colo., United States of America.

Drishti Baid (D)

Sol Price School of Public Policy, University of Southern California, Los Angeles, Calif., United States of America.

Reem F Alsukait (RF)

Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Health, Nutrition and Population Global Practice, World Bank, Riyadh, Saudi Arabia.

Taghred Alghaith (T)

Saudi Health Council, Riyadh, Saudi Arabia.

Mohammed Alluhidan (M)

Saudi Health Council, Riyadh, Saudi Arabia.
Lancaster University, Lancaster, United Kingdom.

Hana Alabdulkarim (H)

Drug Policy and Economic Centre, Ministry of National Guards Health Affairs, Riyadh, Saudi Arabia.

Abdulaziz Altowaijri (A)

Program for Health Assurance and Purchasing, Ministry of Health, Riyadh, Saudi Arabia.

Ziyad S Almalki (ZS)

Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.

Christopher H Herbst (CH)

Health, Nutrition and Population Global Practice, World Bank, Riyadh, Saudi Arabia.

Eric Andrew Finkelstein (EA)

Duke-NUS Medical School, Singapore, Singapore.

Sameh El-Saharty (S)

Health, Nutrition and Population Global Practice, World Bank, Kuwait City, Kuwait.

Nahar Alazemi (N)

Saudi Health Council, Riyadh, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH